ClinConnect ClinConnect Logo
Search / Trial NCT00461188

Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA

Launched by BARTS & THE LONDON NHS TRUST · Apr 16, 2007

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Acromegaly Gigantism Familial Pituitary Adenoma Familial Acromegaly Familial Isolated Pituitary Adenoma Fipa Pituitary Adenoma Predisposition Pap

ClinConnect Summary

This clinical trial is studying the genetic causes of certain types of pituitary tumors, including conditions like acromegaly and gigantism. Researchers want to identify new genes that might increase the risk of developing these tumors, particularly in families where multiple members are affected. The study will start with patients who have a strong family history of pituitary tumors, and it will expand to include other cases as well.

To participate in the trial, individuals should have a family history of acromegaly or other pituitary tumors, have been diagnosed with early onset acromegaly, or have a sporadic (randomly occurring) pituitary tumor. If you decide to join, your doctor will explain the study and help you through the process, which involves providing a blood sample and possibly sharing information about family members who might also participate. Researchers will analyze the samples to look for genetic factors that contribute to these conditions. Your involvement could help improve understanding and treatment for future patients with similar issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Familial acromegaly or other type of pituitary tumour OR
  • Early onset acromegaly or
  • Sporadic pituitary tumour
  • Exclusion Criteria:
  • Do not consent

About Barts & The London Nhs Trust

Barts and The London NHS Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality clinical care, research, and education. As a prominent sponsor of clinical trials, the Trust is dedicated to advancing medical knowledge and improving patient outcomes through innovative research initiatives. With a focus on patient safety and ethical standards, Barts and The London NHS Trust collaborates with multidisciplinary teams to explore cutting-edge therapies and interventions across various medical fields, ensuring that trial participants receive the highest level of care and support throughout their involvement.

Locations

Newcastle Upon Tyne, , United Kingdom

London, , United Kingdom

Leicester, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Marta Korbonits, MD PhD

Principal Investigator

Barts and the London Medical School

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials